Headspace is planning to launch its prescription offerings as soon as 2020, CEO and co-founder Rich Pierson told Cheddar. "It's going to be a separate product to our core consumer for specific disease states," Pierson said. "And then you'll be able to get them prescribed by your doctor, once we have FDA clearance." The new products could give Headspace an edge as it fights for market share over competitor Calm.